Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Triple G agonist shows therapeutic potential in obesity
11 Sep 2023
Treatment with retatrutide, the novel agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, leads to marked reductions in body weight in individuals with obesity, as shown in the results of a phase II trial.
Triple G agonist shows therapeutic potential in obesity
11 Sep 2023HEART-FID confirms IV iron safety for HF but falls short in efficacy
11 Sep 2023
bởiAudrey Abella
The HEART-FID trial narrowly missed its primary endpoint, showing modest improvement in all-cause mortality, heart failure hospitalizations (hHF), and exercise function with ferric carboxymaltose (FCM) in HFrEF* patients with iron deficiency (ID).